Knaus 1985 APACHE II integer: 12 Acute Physiology Score items (worst in 24 hours as assigned by the caller) plus age and chronic-health points, max 71. Oxygenation uses A-aDO2 when FiO2 is at least 0.5 and PaO2 when FiO2 is below 0.5. Creatinine points double in acute renal failure. Does not compute predicted death risk. magent does not measure vitals.

Apfel 1999 simplified PONV risk score. Four caller-assigned predictors, 1 each, max 4: female sex, history of motion sickness or PONV, nonsmoking, postoperative opioids. Male and smokers score 0 on those items. Returns the integer score as bands 0-4. Apfel 1999 reported incidences by score; this tool returns the integer score without those percents. Not a medical device, not a prophylaxis order, not a diagnosis of PONV. Caller assigns history and opioid plan; magent does not take an anesthetic.

Apgar score from five 0-2 newborn signs (appearance, pulse, grimace, activity, respiration). Deterministic published score with citation; not a diagnosis.

Wai 2003 AST to platelet ratio index (APRI) from AST, laboratory AST ULN, and platelet count. Returns APRI to two decimals plus published training-set cut-offs for significant fibrosis (Ishak ≥3) and cirrhosis. ULN is required; magent does not assume 40 U/L. Not a diagnosis, not FIB-4, and not a biopsy.

ARC-HBR (Urban 2019 Table 3). High bleeding risk at PCI iff ≥1 major or ≥2 minor. Binary; no weighted point score. Caller-assigned booleans; magent does not assay labs or read NIHSS. Mutex (400): severe vs moderate CKD, Hb <11 vs mild anemia, major vs minor bleed, moderate-severe stroke <6 mo vs any other ischemic stroke. Not a DAPT duration. Not a medical device.

ARDS Network 2000 predicted body weight (PBW) from height and sex, and the lower-tidal-volume arm 6 mL/kg PBW. Male PBW_kg = 50 + 0.91*(height_cm-152.4); female uses 45.5. Also returns the published 4 mL/kg minimum. Height in cm or inches. Not a ventilator order, plateau-pressure titration, Berlin/AECC diagnosis, pediatric tube size, or ETT insertion depth. Not Devine IBW. Deterministic published arithmetic with citation.

Canet 2010 ARISCAT simplified risk score (Table 6, β×10 rounded; Mazo 2014 reprints the same points): age <=50=0, 51-80=3, >80=16; SpO2 >=96=0, 91-95=8, <=90=24; respiratory infection last month=17; anemia Hb <=10 flag=11; incision peripheral 0, upper_abdominal 15, intrathoracic 24; duration hours <=2=0, >2 to 3=16, >3=23; emergency=8. Max 123. Low <26, intermediate 26-44, high >=45. Not a diagnosis or cancel-surgery order. magent does not measure SpO2.

ASA Physical Status Classification System (ASA House of Delegates 2014, last amended 2020). Caller-assigned class 1-6 plus optional emergency suffix E. Returns asa_label (e.g. 1 or 2E) and the published class definition. Classification alone does not predict perioperative risk. Not an anesthetic plan, not Gupta MICA, not Mallampati. magent does not examine the patient.

ASAS 2009 axial SpA classification (Rudwaleit set 3a / fig 2). Required: chronic back pain ≥3 months and age at onset <45. Imaging arm: MRI or modified New York sacroiliitis plus ≥1 of 11 SpA features. Clinical arm: HLA-B27 plus ≥2 other features (HLA-B27 does not count toward those two). Not a diagnosis. Not peripheral ASAS 2011. Not modified New York AS-only. magent does not read films or assay HLA-B27.

ASAS 2011 peripheral SpA classification (Rudwaleit set 2D / fig 1 + table 5). Required: current arthritis, enthesitis, or dactylitis. Arm A: ≥1 of psoriasis, IBD, preceding infection, HLA-B27, uveitis, sacroiliitis on imaging. Arm B: ≥2 of arthritis, enthesitis, dactylitis, IBP in the past, family history of SpA. Not a diagnosis. Not ASAS 2009 axial. Not ESSG/Amor. magent does not examine joints or assay HLA-B27.

Amarenco 2013 ASCOD phenotyping of ischemic stroke from caller-assigned grades. A atherosclerosis, S small-vessel disease, C cardiac pathology, O other causes, D dissection. Each grade is 1 potentially causal, 2 causality uncertain, 3 unlikely causal but disease present, 0 absent, or 9 insufficient workup. Returns A1-S0-C2-O0-D0 style phenotype, not a summed score. magent does not read imaging. Not TOAST. Not CCS. Not a treatment. Not a medical device.

Goff 2013 ACC/AHA pooled-cohort 10-year hard ASCVD percent for age 40-79 from sex, caller-assigned white or african_american cohort, total and HDL cholesterol, treated or untreated systolic BP, smoking, and diabetes. Table A coefficients. Caller assigns cohort; magent does not assign race and does not apply Recommendation 2 as a silent swap. Not PREVENT 2024, not Framingham CHD, not SCORE2, not a diagnosis or statin order. magent does not assay lipids.

AHA/ACC 2018 Table 4 very high-risk ASCVD for known clinical ASCVD. Very high-risk if ≥2 major events (recent ACS, prior MI, ischemic stroke, symptomatic PAD) or 1 major event and ≥2 high-risk conditions (age ≥65, heterozygous FH, CABG/PCI outside those events, diabetes, hypertension, CKD eGFR 15-59, current smoking, LDL-C ≥100 on max statin and ezetimibe, congestive HF). Not PCE. Not a statin, ezetimibe, or PCSK9 order. magent does not diagnose ASCVD or measure ABI or LDL-C.

van der Heijde 2009 ASDAS-CRP: 0.12*back pain + 0.06*morning stiffness duration + 0.11*patient global + 0.07*peripheral pain/swelling + 0.58*ln(CRP+1). BASDAI 0-10 items and CRP in mg/L. ASAS selected the CRP version as preferred. magent does not examine the patient or assay CRP. Not ASDAS-ESR. Not BASDAI total. Does not apply Machado 2011 1.3/2.1/3.5 activity cuts. Not a diagnosis or biologic order.

Lukas 2009 ASDAS-ESR: 0.08*back pain + 0.07*morning stiffness duration + 0.11*patient global + 0.09*peripheral pain/swelling + 0.29*sqrt(ESR). BASDAI 0-10 items and ESR in mm/h. magent does not examine the patient or assay ESR. Not ASDAS-CRP. Not BASDAI total. Does not apply Machado 2011 1.3/2.1/3.5 activity cuts. Not a diagnosis or biologic order.

Acute Stroke Dysphagia Screen (Edmiaston 2010). Pass only when all five hold: GCS ≥13 and no facial, tongue, or palatal asymmetry or weakness, and no 3-ounce water-swallow aspiration signs. Fail-any screen. Caller assigns GCS and the four bedside flags. magent does not examine cranial nerves or administer water. Not a dysphagia diagnosis, not a diet order, and not a medical device.

Barber 2000 ASPECTS: 10 minus 1 for each caller-assigned MCA region with early ischemic change (C caudate, L lentiform, IC internal capsule, I insular ribbon, M1–M6). Score 0–10. Not pc-ASPECTS. magent does not read the CT. Not a diagnosis, lytic order, or medical device.

Kessler 2005 Adult ADHD Self-Report Scale (ASRS) v1.1 Part A: six caller-assigned 0-4 items (never to very often). wrap_up, organization, and remembering count at sometimes or more; avoid_delay, fidget, and motor count at often or more. Screen-positive at ≥4 of 6. Not an ADHD diagnosis, not a medical device, and not the 18-item ASRS or later 0-24 sum cutoffs. magent does not interpret the items.

Lee 2019 ASTCT CRS Table 1 grade 0-4. Fever (>=38 C, not another cause) with both axes none is grade 1. fever_waived after antipyretic, tocilizumab, or steroids. Grade is the more severe of hypotension (none / no_vasopressors / one_vasopressor / multiple_vasopressors) vs hypoxia (none / low_flow / high_flow / positive_pressure). Organ toxicities do not influence grade. Not ICANS. magent does not measure temperature or start vasopressors.

Adult ASTCT ICANS consensus grade (Lee 2019 Table 6). Grade is the most severe of ICE, depressed LOC, seizure, deep focal motor weakness, and ICP/edema. ICE 10 is 0; 7-9 is 1; 3-6 is 2; 0-2 is 3; ICE 0 is 4 if unarousable. Not CRS, not pediatric CAPD, and not the 10-item ICE test. magent does not perform ICE testing or examine the patient. Not a medical device.

Asthma Predictive Index (Castro-Rodriguez 2000, Tucson Children's Respiratory Study). Stringent positive if early frequent wheeze (parent frequency scale > 3) plus 1+ major or 2+ minor criteria. Loose positive if any early wheeze plus the same risk factors. Majors: parental MD asthma, MD eczema. Minors: MD allergic rhinitis, wheezing apart from colds, circulating eosinophils >4% of WBC (caller-assigned). Not mAPI. Not an asthma diagnosis. magent does not examine the child. Not a medical device.

Ntaios 2012 ASTRAL integer score for 3-month mRS >2 in acute ischemic stroke. Age 1/5 years + NIHSS (caller 0-42) + 2 if onset-to-admission >180 min + 2 if visual field defect + 1 if glucose <3.7 or >7.3 mmol/L (mg/dL /18) + 3 if impaired consciousness. Score 31 is 50% unfavorable. Not a tPA decision. magent does not compute NIHSS.

Miller 2013 ATLAS for Clostridioides difficile: age (<60 0, 60–79 1, ≥80 2), systemic antibiotics during CDI therapy (0 or 2), WBC (<16 0, 16–25 1, >25 ×10^9/L 2), albumin (>35 0, 26–35 1, ≤25 g/L 2), creatinine (≤120 0, 121–179 1, ≥180 µmol/L 2); max 10. Predicted cure percent = 100 − 5.08 × score (1 decimal). Not a CDI diagnosis, stool culture, or metronidazole/vancomycin/fidaxomicin order.

Fang 2011 ATRIA hemorrhage score: anemia caller flag 3 (paper Hb <13 g/dL men or <12 g/dL women); severe renal disease (eGFR <30 or dialysis) caller flag 3; age >=75 scores 2; prior hemorrhage 1; diagnosed hypertension 1. Max 10. Score 0-3 low, 4 intermediate, 5-10 high. Not a diagnosis. Not a warfarin order. Not HAS-BLED. magent does not measure hemoglobin or compute eGFR.

Singer 2013 ATRIA stroke risk score (not Fang 2011 ATRIA bleed). Age x prior stroke Table 3: <65 0/8, 65-74 3/7, 75-84 5/7, >=85 6/9 without/with prior stroke. Plus 1 each: female, diabetes, heart failure, hypertension, proteinuria, eGFR<45 or ESRD. Max 15 (12 without prior stroke). 0-5 low, 6 moderate, 7-15 high. Not a stroke diagnosis or anticoagulation order. Not CHA2DS2-VASc. magent does not assay eGFR or urine.

Eddleston 2004 atropine maintenance infusion after atropinization. infusion_low_mg_h = 0.10 * atropine_load_mg; infusion_high_mg_h = 0.20 * atropine_load_mg. Caller supplies the total atropine loading milligrams already used to stabilize. Not doubling-bolus titration, not pralidoxime, not a prescription. magent does not diagnose organophosphate poisoning and does not choose loading boluses.

Barry 1992 AUA-SI: seven caller-assigned integers 0-5 for incomplete emptying, frequency, intermittency, urgency, weak stream, straining (hesitancy), and nocturia. Sum 0-35. magent does not take a voiding history. Barry 1992 published no mild/moderate/severe total-score bands; later AUA-guideline 0-7/8-19/20-35 cuts are not applied. Not the 8-item IPSS quality-of-life question, not a BPH treatment order, and not a medical device.

Dakik 2019 AUB-HAS2 for 30-day death/MI/stroke after noncardiac surgery: six 1-point elements (history of heart disease, angina or dyspnea, age ≥75, hemoglobin <12 g/dL, vascular surgery, emergency surgery). Low 0-1, intermediate 2-3, high >3 (max 6). Derivation rates 0%, 0.5%, 2.0%, 5.6%, 15.7% by score 0/1/2/3/>3. Not a medical device, not RCRI, not ACS treatment, and not operative clearance.

Bush 1998 AUDIT-C from three caller-assigned integers 0-4 (frequency, typical drinks, binge frequency); magent does not map drink-count categories. Total 0-12. This paper reported ≥3 as sensitive and ≥4 as more specific for heavy drinking / active abuse or dependence in VA outpatients (mostly men). Returns screen_ge_3 and screen_ge_4. Not later sex-specific VA primary-care cutoffs, not the full 10-item AUDIT, and not CIWA-Ar. Not a diagnosis.

Chen 2010 AUSDRISK Box 3 waist model (not BMI). Male 3; age 18-34 0, 35-44 2, 45-54 4, 55-64 6, >=65 8; ancestry atsi_or_asian or southern_european_or_pacific 2 (caller-assigned); parental diabetes 3; high glucose 6; antihypertensives 2; current smoker 2; physically inactive 2; waist cat1/2/3 = 0/4/7 (ATSI/Asian vs other cutoffs). Max 35. at_risk iff score>=12. Not a diagnosis. Not FINDRISC.

Douglas 2013 AWOL: four caller-assigned yes/no flags (age ≥80, unable to spell WORLD backward, not fully oriented to place, nurse-rated illness moderately ill/severely ill/moribund), 1 point each, max 4. Combined-population observed delirium 2/4/14/20/64% at scores 0–4. Deterministic published score with citation; not a delirium diagnosis, not CAM-ICU, not 4AT, and not a medical device. magent does not interview the patient or collect an integer age.

Nigrovic 2002 Bacterial Meningitis Score: CSF Gram stain (2), CSF ANC ≥1000 cells/µL (1), CSF protein ≥80 mg/dL (1), peripheral ANC ≥10 000 cells/µL (1), seizure (1). Max 6. very_low_risk if 0, not_low_risk if ≥1. Children with CSF pleocytosis as in Nigrovic 2002; not a neonatal score. Not a meningitis diagnosis or an antibiotic/LP order. magent does not stain CSF, count neutrophils, assay protein, or witness a seizure.

Soumerai 2019 BALL score for relapsed or refractory CLL. Four caller-assigned 1-point flags (max 4): beta-2-microglobulin at the paper's published cutoff (>=5 mg/dL), LDH > laboratory ULN, anemia (Hb <110 g/L women or <120 g/L men), and time from initiation of last therapy <24 months. Risk low 0-1, intermediate 2-3, high 4. magent does not assay labs or convert B2M mg/L vs mg/dL. Not a treatment recommendation.

Cacciola 2013 Brief Addiction Monitor (BAM; public-domain VA instrument). Three subscales only: Use (items 4+5+6, 0-90), Risk (items 1+2+3+8+11+15, 0-102 on Table 1 0-4 Likert plus 0-30 days), Protective (items 9+10+12+13+14+16, 0-98; income No=0 Yes=30). Items 7a-g and 17 collected, not summed. No total BAM score. magent does not interview the patient. Not a diagnosis, level-of-care order, or medical device.

BAP-65 (Tabak 2009) class I–V for acute exacerbation of COPD. Three caller-assigned main factors: BUN >25 mg/dL, altered mental status (GCS <14 or disoriented/stupor/coma), and pulse >109/min. Age >65 splits class I from II only when zero main factors are present; age is not a fourth additive point. magent does not compute GCS, BUN, or pulse. Not a medical device and not a ventilation or ICU-admission order.

Harrison 2008 BARD score for NAFLD advanced fibrosis: BMI ≥28 kg/m² (1), AST/ALT ≥0.8 (2), diabetes mellitus (1); max 4. Low 0–1, high 2–4 (paper 2–4 vs 0–1 split). Not a NASH diagnosis; magent does not interpret a biopsy or compute BMI. Not FIB-4, APRI, or the NAFLD fibrosis score.

Swift 2002 Behavioural Activity Rating Scale (BARS): caller-assigned integer 1-7 (difficult or unable to rouse; asleep but responds normally to verbal or physical contact; drowsy, appears sedated; quiet and awake, normal activity; signs of overt physical or verbal activity, calms with instructions; extremely or continuously active, not requiring restraint; violent, requires restraint). Returns score, max 7, and a stable label. Not RASS and not a diagnosis. magent does not observe the patient.

Mahoney 1965 Barthel Index: ten caller-assigned activity points (feeding, bathing, grooming, dressing, bowels, bladder, toilet, transfers, mobility, stairs) using that paper's 0/5, 0/5/10, or 0/5/10/15 values. magent sums only (max 100 in fives) and does not observe the patient. Not the Collin 0-20 Barthel and not a disability rating or placement decision.

Bastion classification of lower-limb IED injury (Jacobs 2014). Caller assigns class 1-5 as the most proximal extent. Returns the class description, associated-injury flags (segmental, intraperitoneal abdomen, genital/perineal, pelvic ring, upper limb), and tourniquet_effective (true for class 1-3, false for class 4-5). Not MESS, not ISS AIS, not a treatment protocol. Paper was not designed for mortality or transfusion rates. magent does not examine the casualty.

Rastegar 2017 Brief Alcohol Withdrawal Scale (BAWS): five caller-assigned integers 0-3 (tremor, diaphoresis, agitation, orientation, hallucinations), summed 0-15. BAWS >=3 predicted CIWA-Ar >=8 in that paper (sensitivity 85.3%, specificity 65.8%). magent does not examine the patient or order benzodiazepines. Not later ICU dose bands. Not a medical device.

Reig 2022 BCLC stage 0/A/B/C/D from caller-assigned cancer-related ECOG, preserved liver function, transplant option, vascular invasion, extrahepatic disease, tumor count, and largest diameter. Returns stage and expected median survival only. Not a treatment recommendation. magent does not assign ECOG, compute Child-Pugh, or interpret imaging. Not a medical device. Not Milan or UCSF listing.

BeAM (bedtime minus pre-breakfast glucose) in mg/dL from Zisman 2016. Provide bedtime_glucose_mg_dl or bedtime_glucose_mmol_l independently of AM, and am_glucose_mg_dl or am_glucose_mmol_l. mmol/L converts as mg/dL = mmol/L × 18. Returns beam_mg_dl (1 decimal) and the published analysis band (<0, 0-50, >50). 0 and 50 are 0-50. Does not use a 45 or 55 cutoff, order prandial insulin, or diagnose diabetes.

Fowler 1989 BED without a time or repopulation term: BED = n * d * (1 + d / (alpha/beta)). n equal fractions (1-50), d Gy per fraction (0.5-30), caller-assigned tissue alpha/beta (1-20 Gy). Rounds to 1 decimal. Rejects non-positive n*d or alpha/beta. No T_k/T_pot, no EQD2. Not a radiotherapy prescription. magent does not plan radiotherapy. Not a medical device.

Harris–Benedict 1919 basal energy expenditure (kcal/day) from height, weight, age, and sex. Deterministic published formula with citation; not a nutrition prescription.

Berg 1992 Berg Balance Scale (BBS): fourteen caller-assigned integers 0-4 (sitting to standing through standing on one foot). Sum 0-56. magent does not observe. Berg 1992 printed no 0-20 wheelchair / 21-40 walking-with-assistance / 41-56 independent website bands. Not Timed Up and Go, not a diagnosis, and not a medical device.

Berlin Definition of ARDS (Ranieri 2012). berlin_ards iff clinical box (onset within 1 week, bilateral opacities not fully explained, origin not fully HF or fluid) and severity mild, moderate, or severe. Severe: PF<=100 with PEEP>=5. Moderate: 100<PF<=200 with PEEP>=5. Mild: 200<PF<=300 with PEEP or CPAP>=5. Caller assigns flags and pf_ratio. magent does not read radiographs or echo, diagnose ARDS, or set ventilator mode. Not AECC 1994, not Kigali, not the oxygenation index.

Bicarbonate deficit from weight and measured HCO3 using Adrogué–Madias 50 percent body-weight space. Deterministic published arithmetic with citation; not a dosing protocol.

Binet 1981 CLL staging. Stage C if anemia (Hb <10 g/dL) or thrombocytopenia (platelets <100×10^9/L), regardless of lymphoid areas. Else stage B when involved_areas is 3-5, else stage A when 0-2. The five areas are cervical, axillary, and inguinal (unilateral or bilateral counts as one area each), plus spleen, plus liver; the caller assigns the count. Not a medical device, not a CLL diagnosis, and not Rai staging (Rai anemia is Hb <11).

Wu 2008 BISAP for early mortality prediction in acute pancreatitis: BUN >25 mg/dL, caller-assigned impaired mental status, caller-assigned SIRS, age >60, and caller-assigned pleural effusion; 1 point each, max 5. BUN 25.0 and age 60 do not score. Score only; no mortality percentages. Not a diagnosis. Not Ranson, APACHE II, or CTSI. magent does not recompute SIRS, assign mental status, or read imaging.

Bishop 1964 pelvic score: sum of five caller-assigned integers (dilation 0-3, effacement 0-3, station 0-3, consistency 0-2, position 0-2; max 13). Paper bins: dilation 0 / 1-2 / 3-4 / 5-6 cm; effacement 0-30 / 40-50 / 60-70 / 80%; station -3 / -2 / -1 or 0 / +1 or +2; consistency firm/medium/soft; position posterior/mid/anterior. magent does not examine the cervix and does not add later favorable/unfavorable cutoffs, modified Bishop, or cervical length.